Lv1
10 积分 2026-08-03 加入
Strategies to reduce the use of non-human primates in the development of oncology therapeutics: CD3-bispecifics
9天前
已完结
Advancing drug discovery for inflammatory bowel diseases through human intestinal organoid-based models
9天前
已完结
A Bispecific Modeling Framework Enables the Prediction of Efficacy, Toxicity, and Optimal Molecular Design of Bispecific Antibodies Targeting MerTK
9天前
已完结
TL1A Inhibition in Inflammatory Bowel Disease: A Pipeline Review
1个月前
已完结
皖公网安备34019202002308
